Want to see ES:FACE full AI Analyst Report?
FACE Stock Chart & Stats
€2.53
€0.00(0.00%)
At close: 4:00 PM EST
€2.53
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.78 - €2.88
Previous CloseN/A
Volume1.96K
Average Volume (3M)21.10K
Market Cap
€48.41M
Enterprise Value€58.74M
Total Cash (Recent Filing)€2.21M
Total Debt (Recent Filing)€7.20M
Price to Earnings (P/E)185.0
Beta0.12
Next Earnings
Oct 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding26,624,086
10 Day Avg. Volume10,893
30 Day Avg. Volume21,097
Financial Highlights & Ratios
PEG Ratio-1.75
Price to Book (P/B)3.07
Price to Sales (P/S)1.86
P/FCF Ratio-47.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)€46.10M
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityReturning to positive EBIT and net income in 2025 on +20.7% revenue indicates the company can scale its software licensing and services model more profitably. This improves operational credibility, reduces refinancing risk, and creates a stronger base to fund product development and commercial expansion.
Strengthening Operating Cash FlowOperating cash flow rising to about €7.3M reflects improved cash generation from core operations rather than one-offs. Stronger OCF supports organic investment in R&D and implementation services, lowering dependence on external financing and increasing medium-term financial flexibility.
Improved Leverage / Balance SheetLeverage materially improving to a debt-to-equity of ~0.33 provides greater balance-sheet flexibility. Lower debt burden enhances resilience to cyclical stress, reduces interest costs, and enables management to allocate capital toward growth initiatives or selective M&A without immediate refinancing pressure.
Bears Say
Thin Net MarginsA net margin near 1% leaves minimal buffer against revenue or cost shocks and means small adverse moves can erase profits. Sustained low margins constrain the company's ability to self-fund expansion, reduce returns to shareholders, and require either higher volumes or structural margin improvement to be reliably durable.
Negative Free Cash FlowNegative free cash flow despite stronger operating cash flow indicates ongoing investment or working-capital absorption. Persistent FCF deficits limit capacity to deleverage, invest opportunistically, or return capital without raising funds, making strategic flexibility contingent on converting OCF into sustained positive FCF.
Earnings Volatility / Prior Large LossesHistorical volatility and sizeable losses in 2023-2024 undermine predictability of future results. That inconsistency raises execution risk, can elevate the cost of capital, and means the 2025 improvement must be sustained over multiple periods before investors and customers can reliably trust long-term performance.
Facephi Biometria SA News
FACE FAQ
What was Facephi Biometria SA’s price range in the past 12 months?
Facephi Biometria SA lowest stock price was €1.78 and its highest was €2.88 in the past 12 months.
What is Facephi Biometria SA’s market cap?
Facephi Biometria SA’s market cap is €48.41M.
When is Facephi Biometria SA’s upcoming earnings report date?
Facephi Biometria SA’s upcoming earnings report date is Oct 22, 2026 which is in 100 days.
How were Facephi Biometria SA’s earnings last quarter?
Currently, no data Available
Is Facephi Biometria SA overvalued?
According to Wall Street analysts Facephi Biometria SA’s price is currently Overvalued.
Does Facephi Biometria SA pay dividends?
Facephi Biometria SA does not currently pay dividends.
What is Facephi Biometria SA’s EPS estimate?
Facephi Biometria SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Facephi Biometria SA have?
Facephi Biometria SA has 26,624,086 shares outstanding.
What happened to Facephi Biometria SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Facephi Biometria SA?
Currently, no hedge funds are holding shares in ES:FACE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Facephi Biometria SA
Facephi Biometria, S.A. delivers advanced biometric facial recognition technology solutions, primarily targeting the banking industry across Latin America, the United States, Asia, and other international markets. The company's offerings include "Facephi Beyond Biometrics," a versatile multi-biometric platform for digital identity verification that enables clients to tailor various digital onboarding and authentication processes. "SelphID" is a digital onboarding tool designed for seamless user registration or product contracting remotely. Additionally, "Selphi" provides a biometric authentication solution for verifying user identities. Other specialized solutions from Facephi encompass Look&Phi, PhiVox, inPhinite, and SignPhi. Beyond financial services, their technology is utilized in diverse sectors such as insurance, healthcare, telecommunications, travel and transportation, public administration, shared mobility, and sporting events. Established in 2012, Facephi Biometria, S.A. is headquartered in Alicante, Spain.
Technical Analysis
Izertis SA
―
Substrate Artificial Intelligence SA
―
Airtificial Intelligence Structures SA
―
Seresco SA
―
Aplicaciones y Tratamiento de Sistemas, S.A.
―